SHANNON CLARK: Open Payments
NPI 1508299777 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 66 payments from 21 companies in 2025. Trend: 2023 $956 · 2024 $830 · 2025 $1,462
Food & beverage: $1,462
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $235 |
| Amgen Inc. | 10 | $188 |
| Fresenius USA Marketing, Inc. | 9 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $118 |
| Calliditas Therapeutics US Inc. | 3 | $92 |
| Travere Therapeutics, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| SCPHARMACEUTICALS INC. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Vifor Pharma, Inc. | 2 | $47 |
Products named: JYNARQUE, JARDIANCE, VELPHORO, KRYSTEXXA, TARPEYO, FARXIGA, FUROSCIX, Kerendia.
Industry payments across NC — which companies pay providers there.
